These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2828799)

  • 1. Ability of corticotropin releasing hormone to stimulate cortisol secretion independent from pituitary adrenocorticotropin.
    Fehm HL; Holl R; Späth-Schwalbe E; Born J; Voigt KH
    Life Sci; 1988; 42(6):679-86. PubMed ID: 2828799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
    Tanaka T; Hibi I; Shimizu N; Imura H; Tanaka K; Fukata J; Fujieda K; Ichimura T; Kuribayashi T; Ito K
    Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J; Shimizu N; Imura H; Hibi I; Tanaka K; Tanaka T; Nakagawa S; Takebe K; Kimura K; Yoshinaga K
    Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Maccario M; Giordano R; Broglio F; Camanni F; Ghigo E
    Eur J Endocrinol; 2000 Jul; 143(1):99-104. PubMed ID: 10870037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man.
    Kellner M; Wiedemann K; Holsboer F
    Life Sci; 1992; 50(24):1835-42. PubMed ID: 1317939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-independent effect of ovine corticotropin-releasing hormone on cortisol release in man.
    Azar ST; Turner A; Melby JC
    Am J Med Sci; 1992 Apr; 303(4):217-21. PubMed ID: 1314020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cushing's syndrome with a large pituitary adenoma producing both corticotropin-releasing hormone (CRH) and adrenocorticotropin (ACTH).
    Yamada Y; Ohashi A; Inoue T; Sakaguchi K; Tsujimura T; Okamoto D; Itatani H; Fujimoto N; Kusaka K; Fushimi H
    Intern Med; 2002 Jul; 41(7):549-54. PubMed ID: 12132523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of adrenocorticotrophic hormone receptor by corticotropin-releasing hormone in human fetal adrenal definitive/transitional zone cells.
    Rehman KS; Sirianni R; Parker CR; Rainey WE; Carr BR
    Reprod Sci; 2007 Sep; 14(6):578-87. PubMed ID: 17959886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The corticotropin-releasing hormone test in normal short children: comparison of plasma adrenocorticotropin and cortisol responses to human corticotropin-releasing hormone and insulin-induced hypoglycemia.
    Goji K
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):390-4. PubMed ID: 2538990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA; Rebar RW; LaBarbera AR; Pennington EJ; Liu JH
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human corticotropin-releasing hormone test in normal subjects and patients with hypothalamic, pituitary or adrenocortical disorders.
    Fukata J; Nakai Y; Imura H; Abe K; Aono T; Demura H; Fujita T; Hibi I; Ibayashi H; Igarashi M
    Endocrinol Jpn; 1988 Jun; 35(3):491-502. PubMed ID: 2848692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in alcohol dependence disorder. Preliminary report.
    Bailly D; Dewailly D; Beuscart R; Couplet G; Dumont P; Racadot A; Fossati P; Parquet PJ
    Horm Res; 1989; 31(1-2):72-5. PubMed ID: 2542148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a long-acting somatostatin analogue on pituitary-adrenocortical secretion in normal human subjects.
    Itoh S; Tanaka K; Kumage M; Shimizu N
    Endocrinol Jpn; 1990 Feb; 37(1):131-9. PubMed ID: 2166654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.